Edition:
United States

Cue Biopharma Inc (CUE.OQ)

CUE.OQ on NASDAQ Stock Exchange Capital Market

12.57USD
22 Jun 2018
Change (% chg)

-- (--)
Prev Close
$12.57
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
39,235
52-wk High
$17.76
52-wk Low
$10.40

Chart for

About

Cue Biopharma Inc is a development-stage immunotherapy company. The Company is focused at developing biologics engineered to selectively modulate disease-relevant T cell subsets to treat cancer and autoimmune disease. Its Immuno-Oncology pipeline includes CUE-100 Framework, and CUE-200 Framework; and autoimmune pipeline includes... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $253.04
Shares Outstanding(Mil.): 20.13
Dividend: --
Yield (%): --

Financials

  CUE.OQ Industry Sector
P/E (TTM): -- 248.83 34.14
EPS (TTM): -1.46 -- --
ROI: -- -5.25 13.10
ROE: -- -6.83 15.09

BRIEF-Peter Appel Reports Passive Stake Of 7.6 Pct In Cue Biopharma

* PETER APPEL REPORTS A PASSIVE STAKE OF 7.6 PERCENT IN CUE BIOPHARMA INC AS OF DEC 27, 2017 - SEC FILING Source text: (http://bit.ly/2BWquxU) Further company coverage:

Feb 13 2018

BRIEF-Mark Strome Reports 5.7 Pct Passive Stake In Cue Biopharma

* MARK STROME REPORTS A 5.7 PERCENT PASSIVE STAKE IN CUE BIOPHARMA INC AS OF DECEMBER 27, 2017- SEC FILING Source: (http://bit.ly/2AIDG48) Further company coverage:

Jan 09 2018

Earnings vs. Estimates

No consensus analysis data available.